ArticleCancers2022

Improving Risk Assessment for Metastatic Disease in Endometrioid Endometrial Cancer Patients Using Molecular and Clinical Features: An NRG Oncology/Gynecologic Oncology Group Study.

Yovanni Casablanca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.